RARE

Ultragenyx Pharmaceutical (RARE)

About Ultragenyx Pharmaceutical (RARE)

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Details

Daily high

$39.52

Daily low

$38.65

Price at open

$39.12

52 Week High

$60.37

52 Week Low

$37.02

Market cap

3.7B

Dividend yield

0.00%

Volume

36,737

Avg. volume

754,360

P/E ratio

-6.26

Ultragenyx Pharmaceutical News